Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldhuyzen van Zanten, S J O
Right arrow Articles by Junghard, O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldhuyzen van Zanten, S J O
Right arrow Articles by Junghard, O
Gut 2002;50:iv26-iv30
© 2002 by Gut


DYSPEPSIA MANAGEMENT

Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?

S J O Veldhuyzen van Zanten1, N J Talley2, A L Blum3, E Bolling-Sternevald4, M Sundin5, O Junghard5

1 Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
2 Department of Medicine, University of Sydney, Nepean Hospital, Penrith, Australia
3 Division of Gastroenterology, Department of Medicine, University Hospital, Lausanne, Switzerland
4 Department of Biomedicine and Surgery, University Hospital, Linköping, Sweden
5 AstraZeneca R&D, Mölndal, Sweden

Correspondence to:
Correspondence to:
Dr S J O Veldhuyzen van Zanten, Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Science Centre, Victoria General Site, Room 928, Centennial Building, Halifax, Nova Scotia, Canada B3H 2YG;
zanten{at}is.dal.ca


ABSTRACT
Currently, one of the most important unresolved questions concerning Helicobacter pylori is whether eradication of the organism leads to a sustained improvement in symptoms in patients diagnosed with functional (non-ulcer) dyspepsia. Recently, two very similar studies, the ORCHID and OCAY studies, have been completed and the combined results of these two multicentre, multinational, randomised, double blind, controlled clinical trials are reviewed.


Keywords: clinical trial; dyspepsia; Helicobacter pylori; OCAY study; ORCHID study; quality of life; symptom relief

Abbreviations: GDSS, Glasgow dyspepsia severity score; GORD, gastro-oesophageal reflux disease; GSRS, gastrointestinal symptom rating scale; ITT, intention to treat; MRC, Medical Research Council; OAC, omeprazole 20 mg twice daily, amoxycillin 1000 mg twice daily, and clarithromycin 500 mg twice daily for seven days; PGWB, psychological general well being




This article has been cited by other articles:


Home page
EDUCATION AND PRACTICEHome page
D I Campbell and J E Thomas
Helicobacter pylori infection in paediatric practice
Arch. Dis. Child. Ed. Pract., August 1, 2005; 90(2): ep25 - ep30.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology